Renee Herber

Ms. Herber draws on more than 20 years of experience in the biotechnology sector with emphasis on development of vaccines and early phase medical devices. Her resume includes time spent at PowderJect Vaccines where she served as Study Director of Preclinical Toxicology for development of a needle-free delivery system for DNA-based vaccines. Most recently she was Program Director at Platypus Technologies where her efforts led to commercialization of 11 new products for the life science market. Ms. Herber received her BS in Chemistry from Clarke College (now called Clarke University).